Eleven Therapeutics
About
Eleven Therapeutics is a biotechnology company focused on developing novel RNA-based therapeutics for rare genetic diseases. Founded by world-class scientists, the company leverages its proprietary platform to design and deliver targeted therapies. Eleven Therapeutics aims to address unmet medical needs in patients with debilitating genetic conditions.
Key facts
At-a-glance profile data
- Website
- scionxbio.com
- Headquarters
- London, United Kingdom
- Founded
- 2017
- Employees
- 28
- Total funding
- $22M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 2 Aug 2022 | Seed | $22M | Bill & Melinda Gates Foundation |
Tech stack
Detected on scionxbio.com and in its job posts, last scanned 3 Sept 2026. Run your own scan
- Backend
- Python
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Hiring platform
- BambooHR
Add first review
Frequently asked
How much funding has Eleven Therapeutics raised?
Eleven Therapeutics has raised a total of $22M in funding. The most recent round on record is Seed.
How many employees does Eleven Therapeutics have?
Eleven Therapeutics has approximately 28 people on record.